VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2015) -


Premier Diagnostic Health Services Inc. ("Premier" or the "Company") (CSE:PDH) announces that it has received final approval from the Canadian Securities Exchange for a change of business to become an investment issuer. In connection with the change of business, the Company will change its name, as of today's date, to "Premier Diversified Holdings Inc." Its trading symbol will remain as "PDH."

Effective April 22, 2015, the Company will commence trading under its new name Premier Diversified Holdings Inc. Its common shares have the new ISIN of CA74051Q1054 and the new CUSIP number of 74051Q105.

As an investment issuer, the Company will now focus on generating the highest return on capital for shareholders regardless of industry. The Company anticipates having available funds of approximately $5.7M, with $3.8M currently unallocated and up to $1.9M (33%) available to the CEO to allocate into North American public securities. All investments will be carried out in accordance with the Company's Investment Policy.

"It is a new day for PDH shareholders." stated Sanjeev Parsad, President and CEO. "Our goal is to maximize return on shareholder equity, and now we will not be limited by having to focus solely on the medical industry. Where there is opportunity, PDH can invest!"

On behalf of the Board of Directors

Sanjeev Parsad, President, CEO and Director

The Canadian Securities Exchange (CSE) has not reviewed the adequacy or the accuracy of the contents of this document. Company information can be viewed here: Further information regarding the Company can be found on SEDAR at

Legal Notice Regarding Forward Looking Statements: This news release contains "forward-looking statements" within the meaning of applicable Canadian securities legislation. Forward-looking statements are indicated expectations or intentions. Forward-looking statements in this news release include statements with respect to the Company's change of name, the Company's intentions as an investment issuer and available investment funds. Factors that could cause actual results to be materially different include but are not limited to the following: that the name change and Company's investment plans will not be carried out as described herein, if at all; that the nature of Premier's investment policy will change, that the Company may not be or remain financially stable despite its proposed business running consistently; that the amount of funds available for investment may change; and that the allocation of available funds may change. Investors are cautioned against placing undue reliance on forward-looking statements. It is not our policy to update forward looking statements.

Contact Information:

Premier Diagnostic Health Services Inc.
Sanjeev Parsad
President and CEO
(604) 678.9115 ext 205 or Cell: (604) 612.3965
(604) 678.9279 (FAX)